Media centre

ABPI response to NHS Commercial Framework

23 Feb 2021

The NHS Commercial Framework for New Medicines has been published.

ABPI response to EU data adequacy decision

19 Feb 2021

The European Commission has issued a positive preliminary data adequacy decision for the UK which will allow data to continue to flow freely from the EU to the UK.

ABPI response to Life Science Competitiveness Indicators

15 Feb 2021

The government has published new data on the life science sector in the UK and other countries.

There’s nothing we can’t do or achieve, but people with thalassaemia need understanding and support

17 Feb 2021

Thalassaemia major is a serious, genetic blood disorder. Roanna Maharaj was diagnosed with a severe form of the disease as a baby in the Caribbean. This is her story.

Evolving the UK health system to support innovation for the rare disease community

17 Feb 2021

Nicola Redfern, General Manager of bluebird bio in the UK, describes the commercial challenges for rare disease medicines in the UK and reflects on the opportunities of gene therapies. 

It’s never been more important to tell the great story of vaccines

11 Nov 2020

ABPI Chief Executive talks about the importance of vaccines, as ABPI launches its new campaign, #ValuingVaccines.